A double‐blind placebo‐controlled clinical trial testing the effect of hyperbaric oxygen therapy on brain and cognitive outcomes of mildly cognitively impaired elderly with type 2 diabetes: Study design

INTRODUCTION: Type 2 diabetes (T2D) is a risk factor for dementia. Ischemia due to vascular pathology is hypothesized to be an underlying mechanism for this association. Hyperbaric oxygen therapy (HBOT) is a treatment in which oxygen‐enriched air (up to 100%) is administered to patients in a chamber...

Descripción completa

Detalles Bibliográficos
Autores principales: BenAri, Ori, Efrati, Shai, Sano, Mary, Bendlin, Barbara B., Lin, HungMo, Liu, Xiaoyu, Sela, Inbar, Almog, Ganit, Livny, Abigail, Sandler, Israel, Ben‐Haim, Simona, Sagi, Roy, LeRoith, Derek, Schnaider Beeri, Michal, Ravona‐Springer, Ramit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7153432/
https://www.ncbi.nlm.nih.gov/pubmed/32296731
http://dx.doi.org/10.1002/trc2.12008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7153432/
https://www.ncbi.nlm.nih.gov/pubmed/32296731
http://dx.doi.org/10.1002/trc2.12008

Ejemplares similares